Form 4: Guardant Health Executive Reports Stock Transaction
Insider Transaction (Form 4)
John G. Saia, Chief Legal Officer of Guardant Health, Inc., reported multiple transactions in common stock on October 1, 2026.
Summary
- Option exercise/conversion: acquired 974 Common Stock on October 1, 2026; holds 39,965 after (Direct).
- Option exercise/conversion: acquired 1,668 Common Stock on October 1, 2026; holds 41,633 after (Direct).
- Option exercise/conversion: acquired 2,925 Common Stock on October 1, 2026; holds 44,558 after (Direct).
- Option exercise/conversion: acquired 1,496 Common Stock on October 1, 2026; holds 46,054 after (Direct).
- Tax/exercise-price withholding: disposed of 3,706 Common Stock at $174.75 ($647,624) on October 1, 2026; holds 42,348 after (Direct).
- Option exercise/conversion: disposed of 974 Restricted Stock Units on October 1, 2026 (Direct).
- Option exercise/conversion: disposed of 1,668 Restricted Stock Units on October 1, 2026 (Direct).
- Option exercise/conversion: disposed of 2,925 Restricted Stock Units on October 1, 2026; holds 11,701 after (Direct).
- Option exercise/conversion: disposed of 1,496 Restricted Stock Units on October 1, 2026; holds 8,978 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
John G. Saia — Officer (Chief Legal Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Option exercise/conversion | Common Stock | 974 | — | — | 39,965 |
| 2026-10-01 | Option exercise/conversion | Common Stock | 1,668 | — | — | 41,633 |
| 2026-10-01 | Option exercise/conversion | Common Stock | 2,925 | — | — | 44,558 |
| 2026-10-01 | Option exercise/conversion | Common Stock | 1,496 | — | — | 46,054 |
| 2026-10-01 | Tax/exercise-price withholding | Common Stock | 3,706 | $175 | $647.6K | 42,348 |
| 2026-10-01 | Option exercise/conversion | Restricted Stock Units | 974 | — | — | 0 |
| 2026-10-01 | Option exercise/conversion | Restricted Stock Units | 1,668 | — | — | 0 |
| 2026-10-01 | Option exercise/conversion | Restricted Stock Units | 2,925 | — | — | 11,701 |
| 2026-10-01 | Option exercise/conversion | Restricted Stock Units | 1,496 | — | — | 8,978 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Option exercise/conversion (974 shares) |
| 2026-10-01 | Option exercise/conversion (1,668 shares) |
| 2026-10-01 | Option exercise/conversion (2,925 shares) |
| 2026-10-01 | Option exercise/conversion (1,496 shares) |
| 2026-10-01 | Tax/exercise-price withholding (3,706 shares) |
| 2026-10-01 | Option exercise/conversion (974 shares) |
| 2026-10-01 | Option exercise/conversion (1,668 shares) |
| 2026-10-01 | Option exercise/conversion (2,925 shares) |
| 2026-10-01 | Option exercise/conversion (1,496 shares) |
Keywords
insider transaction, Form 4, GH, Guardant Health, Inc., neutral, John G. Saia
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.